Rare
lephants
Screener
Toggle theme
VERICEL CORPORATION
VCEL
·
Healthcare, Drug Manufacturers - General, United States
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Total Cash from Operations:
$77.2M
Line Item
Value
% of Total
Capital Expenditures
$19.9M
25.8%
Other Investing
$4.1M
5.3%
Other
$53.2M
68.8%
Net Cash Flow
$0
0.0%
Download CSV
